Why is Senores Pharma. falling/rising?

As of 23-Jul, Senores Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs 611.70, which reflects a decrease of Rs 3.55 or 0.58%. The stock has underperformed its sector by 1.09% today, having touched an intraday low of Rs 601.3. Over the past week, the stock has seen a slight decline of 0.53%, although it has performed well over the past month with a return of 16.36%. Despite its healthy long-term growth indicators, such as a significant increase in net sales and operating profit, the stock's recent performance is negatively impacted by a flat result forecast for December 2024 and a high price-to-book value ratio, suggesting an expensive valuation. Additionally, there has been a notable decrease in investor participation, particularly from institutional investors, which has contributed to the stock's downward movement. In the broader market context, the Sensex has shown a slight increase of 0.11% over the past week, contrasting with Senores Pharmaceuticals' decline. While the stock has outperformed the benchmark over the past month and year-to-date, the recent drop in institutional investor stakes and falling delivery volumes indicate a lack of confidence among key market players. This decline in participation from institutional investors, who typically have more resources to assess company fundamentals, may further pressure the stock's price in the short term.